Review
Oncology
Xiuting Liu, Graham D. Hogg, David G. DeNardo
Summary: The success of checkpoint inhibitors in cancer treatment has highlighted the importance of the immune system, particularly in eliciting antitumor responses. While initially thought to primarily target T cells, recent research suggests that these inhibitors may also impact innate immunity, thus playing a significant role in clinical efficacy. Further investigation into the mechanisms of action of checkpoint therapies on innate antitumor responses is crucial for developing effective combination treatments to combat checkpoint resistance in refractory malignancies.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Microbiology
Norma V. V. Solis, Rohan S. S. Wakade, Scott G. G. Filler, Damian J. J. Krysan
Summary: Candida albicans, a commensal of the human gastrointestinal tract, is a common cause of human fungal disease. This study compared the gene expression profiles of C. albicans during oral infection and disseminated infection of the kidney, revealing niche-specific differences in gene expression. The findings shed light on the interactions between the pathogen and the host.
Article
Microbiology
Jessica Saul-McBeth, John Dillon, Dylan Launder, Maura Hickey, Elise Mein-Chiain Yi, Yusuf Daboul, Priosmita Biswas, Elahheh Salari, E. Ishmael Parsai, Heather R. Conti
Summary: The study investigates how IL-17 signaling protects against Candida albicans infections in head-neck irradiation-induced inflammatory damage, finding that IL-17 plays a crucial role in promoting oral epithelial regeneration and immune balance against fungal infections.
Article
Multidisciplinary Sciences
Tom Snir, Hagit Philip, Miri Gordin, Alona Zilberberg, Sol Efroni
Summary: Immunotherapy plays a crucial role in cancer treatment, and the unique characteristics of an individual's T cell receptor repertoire are essential for its effectiveness. This study analyzed the repertoire through sequencing and generated a longitudinal dataset of T cell clones and their abundance after anti-CTLA-4 treatment in a mouse model for colorectal cancer. The dynamics of the repertoire over four weeks showed the ascending and descending clonal expansion of specific clones in response to treatment. The data can be used for treatment determination and prediction of its effect, as well as providing insights into the behavior of the immune system over time.
Article
Microbiology
Norma Solis, Rohan S. Wakade, Virginia E. Glazier, Tomye L. Ollinger, Melanie Wellington, Aaron P. Mitchell, Scott G. Filler, Damian J. Krysan
Summary: Oropharyngeal candidiasis (OPC) is a common infection that can range from mild to severe, depending on the patient. The transcriptional regulation of C. albicans biofilm formation on abiotic surfaces involves six key factors, some of which play roles in OPC infectivity in a mouse model. The relationship between fungal burden, hyphae morphogenesis, and infectivity is of significant research interest.
Article
Microbiology
Norma V. Solis, Rohan S. Wakade, Virginia E. Glazier, Tomye L. Ollinger, Melanie Wellington, Aaron P. Mitchell, Scott G. Filler, Damian J. Krysan
Summary: Oropharyngeal candidiasis (OPC) is a common infection that can cause mild or severe disease depending on the patient. The transcriptional regulation of C. albicans biofilm formation on abiotic surfaces is also involved in OPC, but the network characteristics and functional connections during infection are distinct from those observed in vitro.
Review
Immunology
Patricia Almendro-Vazquez, Rocio Laguna-Goya, Estela Paz-Artal
Summary: SARS-CoV-2-specific T cell response is crucial for viral clearance, COVID-19 outcome, and long-term memory. Impaired early T cell-driven immunity leads to severe disease, while an early induction of specific T cells followed by antibody production is associated with a mild course. Delayed and persistent CD8+ T cell activation may contribute to lung pathology. Long-term maintenance of T cell response appears more stable than antibody levels. T cell responses are conserved against variants of concern, and current COVID-19 vaccination elicits a protective T cell response.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Oncology
Christine McInnis, Shilpa Bhatia, Brinda Vijaykumar, Qiaomu Tian, Yanbo Sun, Del Leistritz-Edwards, Charles T. Quinn, Ravi Uppaluri, Ann Marie Egloff, Lakshmi Srinivasan, Daniel C. Pregibon, Anthony J. Coyle, Glenn J. Hanna
Summary: This study conducted a comprehensive single-cell analysis of the immune landscape in HPV-related oropharyngeal squamous cell carcinomas. It identified strong cytotoxic T-cell responses to HPV16 E1 and E2 proteins, suggesting these antigens as potential targets for therapy.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2023)
Article
Multidisciplinary Sciences
Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, David K. Butler, Ashley D. Otter, Katia Menacho, Marianna Fontana, Angelique Smit, Jane E. Sackville-West, Teresa Cutino-Moguel, Mala K. Maini, Benjamin Chain, Mahdad Noursadeghi, Tim Brooks, Amanda Semper, Charlotte Manisty, Thomas A. Treibel, James C. Moon, Ana M. Valdes, Aine McKnight, Daniel M. Altmann, Rosemary Boyton
Summary: Vaccination with a single dose of BNT162b2 after prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants. In contrast, individuals without prior infection showed reduced immunity against variants after receiving a single vaccine dose.
Article
Oncology
Khalid W. Kalim, Jun-Qi Yang, Mark Wunderlich, Vishnu Modur, Phuong Nguyen, Yuan Li, Ting Wen, Ashley Kuenzi Davis, Ravinder Verma, Qing Richard Lu, Anil G. Jegga, Yi Zheng, Fukun Guo
Summary: Targeting Cdc42 in Treg cells has shown promising therapeutic potential in cancer immunotherapy, by enhancing antitumor T-cell immunity without triggering autoimmune reactions. This approach involves inducing Treg cell instability through Cdc42 targeting, leading to improved immune responses against tumors.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2022)
Article
Cell Biology
Li -Jun Duan, Xiao-Ming Cui, Ka -Li Zhu, Lin Yao, Guo-Lin Wang, Wu -Chun Cao, Mai -Juan Ma
Summary: Vaccination with Ad5-nCoV in SARS-CoV-1 survivors enhances antibody response against SARS-CoV-1 but has limited neutralizing antibody activity against SARS-CoV-2 variants, particularly the Omicron subvariants. However, the T cell response to SARS-CoV-2 is comparable between Ad5-nCoV immunized SARS-CoV-1 survivors and Ad5-nCoV immunized naive healthy individuals, while immunized SARS-CoV-1 survivors exhibit a robust cross-reactive T cell response to SARS-CoV-1.
Article
Medicine, Research & Experimental
Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Be-Sheng Kuo, Juin-Hua Huang, Hope Liu, Yu-Hsin Ho, Feng Lin, Shuang Ding, Zhi Liu, Huan-Ting Wu, Ching-Tai Huang, Yuarn-Jang Lee, Ming-Che Liu, Yi-Ching Yang, Po-Liang Lu, Hung-Chin Tsai, Chen-Hsiang Lee, Zhi-Yuan Shi, Chun-Eng Liu, Chun-Hsing Liao, Feng-Yee Chang, Hsiang-Cheng Chen, Fu-Der Wang, Kuo-Liang Hou, Jennifer Cheng, Min-Sheng Wang, Ya-Ting Yang, Han-Chen Chiu, Ming-Han Jiang, Hao-Yu Shih, Hsuan-Yu Shen, Po-Yen Chang, Yu-Rou Lan, Chi-Tian Chen, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, Yu-Chi Chou, Mary Kate Morris, Carl V. Hanson, Farshad Guirakhoo, Michael Hellerstein, Hui-Jing Yu, Chwan-Chuen King, Tracy Kemp, D. Gray Heppner, Thomas P. Monath
Summary: The UB-612 vaccine showed favorable safety profile, long-lasting antibody response, and broad T cell immunity against SARS-CoV-2 variants, including Delta and Omicron, in phase I/II trials.
JOURNAL OF CLINICAL INVESTIGATION
(2022)
Review
Immunology
Jiaqi Huang, Jie Zhang, Zhengyang Guo, Chen Li, Zhen Tan, Junjie Wang, Jianling Yang, Lixiang Xue
Summary: EZH2 is the catalytic subunit of PRC2, regulating gene expression by trimethylation of H3 lysine 27, and is associated with various cancers. Studies indicate that EZH2 may also regulate T cell development, differentiation, and function, impacting immune homeostasis.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Yaroslav Kaminskiy, Jan Joseph Melenhorst
Summary: This review summarizes the role of STAT3 in the formation of memory T cells and antitumor immunity, highlighting its crucial role in long-term T cell immunity.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Oncology
Aakash P. Desai, Farhad Kosari, Maria Disselhorst, Jun Yin, Alireza Agahi, Tobias Peikert, Julia Udell, Sarah H. Johnson, James Smadbeck, Stephen Murphy, Giannoula Karagouga, Alexa McCune, Janet Schaefer-Klein, Mitesh J. Borad, John Cheville, George Vasmatzis, Paul Baas, Aaron Mansfield
Summary: Two unique TCR clusters associated with survival were identified in patients with pleural mesothelioma treated with ICI. These clusters may provide insights for antigen discovery and the design of adoptive T cell therapies.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2023)